Genocea Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Cash & Equivalents	20.14	37.15	79.77	40.13	26.36	12.27
Cash & Short-Term Investments	20.14	37.15	79.77	40.13	26.36	12.27
Cash Growth	-69.51%	-53.43%	98.79%	52.22%	114.79%	-80.63%
Prepaid Expenses	4.27	4.67	2.46	1.46	0.7	0.81
Total Current Assets	24.41	41.82	82.23	41.58	27.06	13.08
Property, Plant & Equipment	13.5	13.26	14.43	8.92	2.58	3.46
Long-Term Deferred Charges	-	-	-	-	-	0.57
Other Long-Term Assets	0.88	0.88	1.84	2.1	1.48	0.38
Total Assets	38.79	55.97	98.49	52.61	31.12	17.49
Accounts Payable	0.59	0.5	0.53	0.55	1.66	3.52
Accrued Expenses	7.55	8.25	5.37	3.85	2.91	4.72
Current Portion of Long-Term Debt	4.7	4.64	13.86	-	5.26	6.66
Current Portion of Leases	2.41	2.35	1.61	1.12	-	-
Current Unearned Revenue	1.56	1.7	1.64	-	-	-
Other Current Liabilities	1.21	1.25	1.97	0.76	0.91	0.89
Total Current Liabilities	18.03	18.68	25	6.28	10.73	15.78
Long-Term Debt	2.95	4.15	-	13.41	9.57	7.65
Long-Term Leases	5.43	6.05	8.4	5.4	-	-
Other Long-Term Liabilities	-	0.01	56.12	2.49	3.48	0.11
Total Liabilities	26.4	28.89	89.51	27.57	23.78	23.54
Common Stock	0.06	0.06	0.05	0.03	0.01	0.03
Additional Paid-In Capital	436.17	434.88	383.6	355.27	298.63	258.11
Retained Earnings	-423.84	-407.86	-374.67	-330.95	-292	-264.19
Total Common Equity	12.39	27.08	8.98	24.34	6.63	-6.05
Shareholders' Equity	12.39	27.08	8.98	25.04	7.34	-6.05
Total Liabilities & Equity	38.79	55.97	98.49	52.61	31.12	17.49
Total Debt	15.49	17.19	23.87	19.92	14.82	14.31
Net Cash (Debt)	4.65	19.96	55.9	20.21	11.54	-2.04
Net Cash Growth	-89.97%	-64.28%	176.60%	75.13%	-	-
Net Cash Per Share	0.07	0.29	1.20	0.98	1.12	-0.57
Filing Date Shares Outstanding	58.78	58.73	53.52	27.64	14.05	3.59
Total Common Shares Outstanding	58.73	58.23	53.02	27.45	10.85	3.59
Working Capital	6.38	23.14	57.23	35.3	16.33	-2.7
Book Value Per Share	0.21	0.47	0.17	0.89	0.61	-1.69
Tangible Book Value	12.39	27.08	8.98	24.34	6.63	-6.05
Tangible Book Value Per Share	0.21	0.47	0.17	0.89	0.61	-1.69
Machinery	-	6.26	5.27	4.92	4.55	4.53
Construction In Progress	-	0.45	0.61	0.1	-	-
Leasehold Improvements	-	1.41	3.27	1.52	1.52	1.52

Updated May 5, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.